Cohen Klingenstein’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $149M | Hold |
129,013
| – | – | 4.26% | 6 |
|
|
2026
Q2 | $155M | Sell |
129,013
-45
| -0% | -$46K | 4.43% | 5 |
|
|
2026
Q1 | $119M | Sell |
129,058
-935
| -0.7% | -$948K | 3.84% | 5 |
|
|
2025
Q4 | $140M | Sell |
129,993
-230
| -0.2% | -$220K | 4.24% | 5 |
|
|
2025
Q3 | $99.4M | Hold |
130,223
| – | – | 3.11% | 8 |
|
|
2025
Q2 | $102M | Sell |
130,223
-241
| -0.2% | -$187K | 3.39% | 7 |
|
|
2025
Q1 | $108M | Hold |
130,464
| – | – | 3.9% | 5 |
|
|
2024
Q4 | $101M | Sell |
130,464
-8,000
| -6% | -$6.62M | 3.45% | 8 |
|
|
2024
Q3 | $123M | Hold |
138,464
| – | – | 4.27% | 6 |
|
|
2024
Q2 | $125M | Sell |
138,464
-1,798
| -1% | -$1.44M | 4.55% | 6 |
|
|
2024
Q1 | $109M | Sell |
140,262
-70
| -0% | -$49.8K | 4.06% | 7 |
|
|
2023
Q4 | $81.8M | Sell |
140,332
-2,234
| -2% | -$1.3M | 3.34% | 8 |
|
|
2023
Q3 | $76.6M | Hold |
142,566
| – | – | 3.47% | 7 |
|
|
2023
Q2 | $66.9M | Sell |
142,566
-299
| -0.2% | -$125K | 2.9% | 9 |
|
|
2023
Q1 | $49.1M | Hold |
142,865
| – | – | 2.3% | 11 |
|
|
2022
Q4 | $52.3M | Sell |
142,865
-2,535
| -2% | -$899K | 2.63% | 11 |
|
|
2022
Q3 | $47M | Hold |
145,400
| – | – | 2.49% | 10 |
|
|
2022
Q2 | $47.1M | Hold |
145,400
| – | – | 2.36% | 10 |
|
|
2022
Q1 | $41.6M | Hold |
145,400
| – | – | 1.73% | 12 |
|
|
2021
Q4 | $40.2M | Sell |
145,400
-50,000
| -26% | -$12.7M | 1.59% | 13 |
|
|
2021
Q3 | $45.1M | Sell |
195,400
-6,300
| -3% | -$1.55M | 1.97% | 10 |
|
|
2021
Q2 | $46.3M | Hold |
201,700
| – | – | 1.99% | 11 |
|
|
2021
Q1 | $37.7M | Hold |
201,700
| – | – | 1.74% | 12 |
|
|
2020
Q4 | $34.1M | Hold |
201,700
| – | – | 1.7% | 11 |
|
|
2020
Q3 | $29.9M | Sell |
201,700
-900
| -0.4% | -$139K | 1.68% | 11 |
|
|
2020
Q2 | $33.3M | Hold |
202,600
| – | – | 2.04% | 9 |
|
|
2020
Q1 | $28.1M | Hold |
202,600
| – | – | 2.08% | 10 |
|
|
2019
Q4 | $26.6M | Hold |
202,600
| – | – | 1.55% | 13 |
|
|
2019
Q3 | $22.7M | Buy |
202,600
+10,000
| +5% | +$1.11M | 1.42% | 14 |
|
|
2019
Q2 | $21.3M | Sell |
192,600
-10,000
| -5% | -$1.18M | 1.52% | 13 |
|
|
2019
Q1 | $26.3M | Buy |
202,600
+108,000
| +114% | +$13.1M | 1.83% | 12 |
|
|
2018
Q4 | $10.9M | Hold |
94,600
| – | – | 1.65% | 11 |
|
|
2018
Q3 | $10.2M | Hold |
94,600
| – | – | 1.29% | 13 |
|
|
2018
Q2 | $8.07M | Hold |
94,600
| – | – | 1.1% | 16 |
|
|
2018
Q1 | $7.32M | Hold |
94,600
| – | – | 1.04% | 17 |
|
|
2017
Q4 | $7.99M | Hold |
94,600
| – | – | 1.14% | 15 |
|
|
2017
Q3 | $8.09M | Hold |
94,600
| – | – | 1.22% | 13 |
|
|
2017
Q2 | $7.79M | Hold |
94,600
| – | – | 1.21% | 13 |
|
|
2017
Q1 | $7.96M | Hold |
94,600
| – | – | 1.27% | 13 |
|
|
2016
Q4 | $6.96M | Hold |
94,600
| – | – | 1.19% | 14 |
|
|
2016
Q3 | $7.59M | Hold |
94,600
| – | – | 1.32% | 13 |
|
|
2016
Q2 | $7.45M | Hold |
94,600
| – | – | 1.37% | 12 |
|
|
2016
Q1 | $6.81M | Hold |
94,600
| – | – | 1.28% | 13 |
|
|
2015
Q4 | $7.97M | Hold |
94,600
| – | – | 1.49% | 11 |
|
|
2015
Q3 | $7.92M | Hold |
94,600
| – | – | 1.56% | 12 |
|
|
2015
Q2 | $7.9M | Hold |
94,600
| – | – | 1.42% | 13 |
|
|
2015
Q1 | $6.87M | Hold |
94,600
| – | – | 1.25% | 17 |
|
|
2014
Q4 | $6.53M | Hold |
94,600
| – | – | 1.22% | 21 |
|
|
2014
Q3 | $6.14M | Hold |
94,600
| – | – | 1.08% | 23 |
|
|
2014
Q2 | $5.88M | Hold |
94,600
| – | – | 1.12% | 23 |
|
|
2014
Q1 | $5.57M | Hold |
94,600
| – | – | 1.11% | 22 |
|
|
2013
Q4 | $4.82M | Hold |
94,600
| – | – | 0.96% | 24 |
|
|
2013
Q3 | $4.76M | Sell |
94,600
-800
| -0.8% | -$41.9K | 1.04% | 23 |
|
|
2013
Q2 | $4.69M | Buy |
+95,400
| New | +$5.19M | 1.09% | 21 |
|
Other funds holding LLY
Cohen Klingenstein's LLY Position: Q3 2026 in Review
Cohen Klingenstein held its Eli Lilly (LLY) position steady in Q3 2026 at 129,013 shares worth $149M. The position accounts for 4.26% of the portfolio, ranked #6.
Cohen Klingenstein first reported a position in LLY in Q2 2013 and has held it in 54 quarters since. The position peaked at $155M in Q2 2026. 2,006 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Cohen Klingenstein held 129,013 shares of Eli Lilly worth $149M as of Q3 2026.
- Cohen Klingenstein left its Eli Lilly share count unchanged in Q3 2026.
- Eli Lilly made up 4.26% of Cohen Klingenstein's portfolio in Q3 2026, its #6 holding.
- Cohen Klingenstein first reported a position in Eli Lilly in Q2 2013 and has held it in 54 quarters since.
- Cohen Klingenstein's Eli Lilly position peaked at $155M in Q2 2026.
- 2,006 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Cohen Klingenstein's 13F filing for Q3 2026, filed 15 Oct 2026.